Alzamend Neuro, Inc.
NASDAQ:ALZN
2.32 (USD) • At close September 5, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||||
| Net Income
| -4.515 | -9.948 | -14.878 | -12.362 | -5.047 | -4.41 | -4.862 | -0.932 | -1.57 | -0.069 |
| Depreciation & Amortization
| 0.051 | 0.051 | 0.023 | 0.004 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Income Tax
| 0 | 0 | -1.707 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 0.325 | 0.956 | 3.583 | 4.409 | 2.032 | 1.802 | 0.396 | 0.218 | 0.114 | 0.041 |
| Change In Working Capital
| -2.438 | 0.671 | 2.349 | 1.327 | -0.152 | -0.299 | 1.23 | -1.347 | -0.05 | -0.006 |
| Accounts Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables
| 0 | 0 | 1.707 | 0.694 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Working Capital
| -2.438 | 0.671 | -1.707 | 0.634 | -0.152 | -0.299 | 1.23 | -1.347 | -0.05 | -0.006 |
| Other Non Cash Items
| 0.009 | 0.001 | 1.707 | 0.009 | 0.455 | 0.562 | 2.191 | 0.227 | 0.088 | 0.016 |
| Operating Cash Flow
| -6.568 | -8.27 | -8.923 | -6.614 | -2.712 | -2.346 | -1.045 | -2.052 | -1.417 | -0.018 |
| Investing Activities: | ||||||||||
| Investments In Property Plant And Equipment
| -0.3 | -0.147 | 0 | -0.106 | 0 | 0 | 0 | 0 | 0 | 0 |
| Acquisitions Net
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| 0 | 0 | 0 | 5.375 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 0 | 0 | 0 | -5.375 | 0.101 | 0.105 | 0.234 | -0.4 | 0 | 0 |
| Investing Cash Flow
| -0.3 | -0.147 | 0 | -0.106 | 0.101 | 0.105 | 0.234 | -0.4 | 0 | 0 |
| Financing Activities: | ||||||||||
| Debt Repayment
| 0 | 0.3 | 0 | 0 | 0.4 | 0 | 0 | -0.364 | 0 | 0 |
| Common Stock Issued
| 2.704 | 1.252 | 0.989 | 18.911 | 2.1 | 2.288 | 0.236 | 3.615 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 7.737 | 2.1 | 0 | 18.855 | 4.05 | 2.288 | 0.073 | -0.259 | 1.421 | 0.025 |
| Financing Cash Flow
| 10.441 | 3.652 | 0 | 18.855 | 4.45 | 2.288 | 0.309 | 2.992 | 1.421 | 0.025 |
| Other Information: | ||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 3.573 | -4.765 | -8.923 | 12.135 | 1.839 | 0.048 | -0.502 | 0.54 | 0.004 | 0.007 |
| Cash At End Of Period
| 3.949 | 0.376 | 5.141 | 14.064 | 1.929 | 0.09 | 0.043 | 0.545 | 0.005 | 0.007 |